News & Blog
News & Blog
Press Release & Community Statement: Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia
Press Release: Update from Lexeo Therapeutics
May/June 2026 – Advocacy Newsletter
Webinar Recording: Solid Biosciences May 2026
Community Letter: Update from PTC Therapeutics
Recordings Available: FARA Flash Talks 2026
Recordings are now available for the 2026 FARA Flash Talks! If you were unable to watch this year's Flash Talks live, please view the se...
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in FA
Press release and community statement: Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights
May is FA Awareness Month: Help raise awareness and move research forward!
April 2026 – Advocacy Newsletter